Domain Therapeutics Enters into Collaboration with XOMA

News   Feb 05, 2014

 
Domain Therapeutics Enters into Collaboration with XOMA
 
 
 

RELATED ARTICLES

New Treatment Target for Melanoma

News

Researchers in the Perelman School of Medicine at the University of Pennsylvania have identified a new therapeutic target for the treatment of melanoma.

READ MORE

Concept Life Sciences appoints New Group Programme Manager and US Head of Sales

News

Key leadership appointments support integration of the Group and expansion in the US market.

READ MORE

Blood-vessel-on-a-chip Provides Insight into Novel Anti-Inflammatory Drug Candidate

News

Researchers have discovered that synthetic APC-mimicking small molecules called “parmodulins” provide anti-inflammatory and anti-thrombotic protection to endothelial cells on par with APC’s without interfering with normal blood clotting and coagulation, making them attractive new drug candidates.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE